scispace - formally typeset
L

Linghong Huang

Researcher at University of Sheffield

Publications -  20
Citations -  541

Linghong Huang is an academic researcher from University of Sheffield. The author has contributed to research in topics: Tissue transglutaminase & Medicine. The author has an hindex of 10, co-authored 13 publications receiving 458 citations. Previous affiliations of Linghong Huang include Northern General Hospital.

Papers
More filters
Journal ArticleDOI

Transglutaminase inhibition ameliorates experimental diabetic nephropathy

TL;DR: It is suggested that transglutaminase inhibition ameliorates the progression of experimental diabetic nephropathy and can be considered for clinical application.
Journal ArticleDOI

Inhibition of Transglutaminase Activity Reduces Extracellular Matrix Accumulation Induced by High Glucose Levels in Proximal Tubular Epithelial Cells

TL;DR: Tg inhibition reduces glucose-induced deposition of ECM proteins independently of changes in ECM and transforming growth factor β1 synthesis thus opening up its possible application in the treatment other fibrotic and scarring diseases where tTg has been implicated.
Journal ArticleDOI

Development of a chronic kidney disease model in C57BL/6 mice with relevance to human pathology.

TL;DR: AAN can be induced in C57BL/6 mice with substantial tubulointerstitial fibrosis with lesions similar to those in humans.
Journal ArticleDOI

Syndecan-4 Knockout Leads to Reduced Extracellular Transglutaminase-2 and Protects against Tubulointerstitial Fibrosis

TL;DR: The lack of Sdc4 heparan sulfate chains in the kidneys of SDC4-null mice abrogates injury-induced externalization of TG2, thereby preventing profibrotic crosslinking of extracellular matrix and recruitment of large latent TGF-β1.
Journal ArticleDOI

Modulation of tissue transglutaminase in tubular epithelial cells alters extracellular matrix levels: a potential mechanism of tissue scarring.

TL;DR: It is reported that TG2 contributes to ECM accumulation primarily by accelerating collagen deposition, but also by altering the susceptibility of the tubular ECM to decay, support a role for TG2 in the expansion of the ECM associated with kidney scarring.